Real-world five-year outcomes of FlexyRap(®) cobalt-chromium rapamycin-eluting stents with biodegradable polymer in patients with de-novo coronary artery disease

BACKGROUND: The use of biodegradable polymer drug-eluting stents (BP-DES) has been proven to minimize restenosis and stent thrombosis. The current post-marketing monitoring was observed at the 5-year clinical outcomes of individuals who had been treated with FlexyRap(®) DES in the real world. AIM: T...

Descripción completa

Detalles Bibliográficos
Autores principales: Garg, Nitish, Chawla, Raman, Tandon, Vivek, Garg, Deepak, Parshottam, Nilesh, Vani, Preeti, Neuss, Malte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074995/
https://www.ncbi.nlm.nih.gov/pubmed/37033681
http://dx.doi.org/10.4330/wjc.v15.i3.84

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074995/
https://www.ncbi.nlm.nih.gov/pubmed/37033681
http://dx.doi.org/10.4330/wjc.v15.i3.84

Ejemplares similares